PEG-rhGH + semaglutide

PEG-rhGH + semaglutide is a combination therapy currently being investigated for non-diabetic individuals. This combination pairs pegylated recombinant human growth hormone (PEG-rhGH) with semaglutide, a GLP-1 receptor agonist. The combination is being studied in clinical trials, with a focus on evaluating its efficacy and safety compared to semaglutide alone. According to the search results, there is an ongoing clinical trial (NCT06863363) that aims to assess this combination therapy in non-diabetic patients. Semaglutide, one component of this combination, is already FDA-approved for treating type 2 diabetes and chronic weight management in patients with obesity. It works by mimicking the effects of glucagon-like peptide-1 (GLP-1), which helps regulate blood sugar levels, enhance insulin secretion, and increase feelings of fullness. PEG-rhGH (pegylated recombinant human growth hormone) is a modified version of human growth hormone that has been conjugated with polyethylene glycol (PEG) to extend its half-life in the body. This modification helps reduce the frequency of administration while maintaining therapeutic effects. The combination therapy appears to be focused on body composition changes, as indicated by research into biomarkers predicting response to PEG-rhGH and semaglutide combination therapy. ## Development Status This combination therapy is currently in clinical trials. The search results mention a specific trial (NCT06863363) that is investigating the efficacy and safety of PEG-rhGH Injection combined with Semaglutide Injection versus Semaglutide Injection alone. ## Potential Mechanisms and Effects While the specific mechanisms of the combination aren't fully detailed in the search results, we can infer from the individual components: - Semaglutide acts as a GLP-1 receptor agonist, helping to reduce hunger, decrease caloric intake, and improve glycemic control - PEG-rhGH likely provides the benefits of growth hormone, which can include increased lean muscle mass and improved metabolism The combination may offer synergistic effects for weight management and body composition improvement, though specific outcomes from the clinical trials are not yet available in the search results.

Other names

PEG-rhGH + semaglutide